Similarly, gp120 treatment resulted in 6–10% increase in oxygen consumption and ATP production, indicating that oxidative phosphorylation is also affected by gp120 in glioma cells, although to a lower extent than the glycolytic pathway. This evidence concerns the gene ITIH4 and central nervous system cancer.